Skip to main content

Bioanalysis Zone is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Awards
  • Events
  • Features
    • An author's perspective
    • Ask the Experts
    • Conference reports
    • eBooks
    • Expert opinion
    • In the Zone
    • Journal articles
    • Journal content
    • Spotlights
    • Tech Digest

    Follow us on social media

  • Glossary
  • Topics
    • Applications
      • Advanced therapies
      • Biomarkers
      • Clinical
      • Diagnostics
      • Drug development
      • Forensics
      • Patient-centric sampling
      • Sports drug testing
      • Toxicology
      • Vaccines
    • Industry updates & regulations
      • Biopharmaceuticals
      • Collaborations & mergers
      • Data processing and interpretation
      • Regulated bioanalysis
    • Molecules
      • Antibodies | ADCs
      • Biosimilars
      • Large molecules
      • Metabolites
      • Oligonucleotides
      • Small molecules
    • Techniques
      • Automation
      • Biosensors
      • Chromatography
      • Flow Cytometry
      • Imaging
      • LBA
      • Microsampling
      • MS (LC–MS/MS, HRMS, IMS)
      • Sample preparation

    Follow us on social media

  • Multimedia
    • Coffee chats
    • Infographics
    • Interviews
    • Panel discussions
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • News
  • Partners
  • Register
LC–MS strategies for advanced modalities: ADC, AOC, multidomain and RNA therapeutics 2 days 2 hours 54 mins 48 secs REGISTER NOW

Echo® MS System for high-throughput analysis

2 Nov 2020
Written by SCIEX
Drug development MS (LC–MS/MS, HRMS, IMS)

This presentation outlines the analytical challenges in MS-based screening, acoustic ejection mass spectrometry technology and the application of the Echo® MS System beyond drug discovery and development.

 

SPOTLIGHT-Echo-MS press-release slides-Chang-min


This content was supplied by SCIEX. 

Top content

  • eBook: Precision bioanalysis for every molecule
  • Global initiative seeks to fast-track personalized therapies for rare diseases
  • Editor’s highlights from NextGen Biomed 2026

Related tags

LC-MS sciex
Previous article Next article

Related articles

18 JUN 2013 INTERVIEWS
Interview with Mike Oliver on sample preparation method optimization for increased efficiency in bioanalytical workflows
17 MAR 2016 CHROMATOGRAPHY
What will be the topic for our final Spotlight of 2016? You decide!
14 FEB 2022 BIOPHARMACEUTICALS
Infographic: current trends in nitrosamine analysis
11 FEB 2026 NEWS
SCIEX integrates the Echo MS+ system with the ZenoTOF 8600 system
28 FEB 2010 CHROMATOGRAPHY
Human microdosing for the prediction of patient response
6 OCT 2016 NEWS
Researchers use Mass Spec to find new biomarker for pancreatic cancer
  • About
  • Advertising & Sponsorship
  • Learn
    • Awareness
    • Education zone
    • Professional development
  • Contact Us
  • Permissions
  • Products
  • Zone Leaders
  • Whitelist Emails
  • Accessibility
  • Editorial Policies

Contact

Contact Us

Office info

Bioanalysis Zone is powered by Taylor & Francis Group

Bioanalysis Zone, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2026 Bioanalysis Zone